EP4698152A1 - Pharmazeutische zusammensetzung zur impfung gegen cytomegalovirusinfektionen - Google Patents

Pharmazeutische zusammensetzung zur impfung gegen cytomegalovirusinfektionen

Info

Publication number
EP4698152A1
EP4698152A1 EP24733697.7A EP24733697A EP4698152A1 EP 4698152 A1 EP4698152 A1 EP 4698152A1 EP 24733697 A EP24733697 A EP 24733697A EP 4698152 A1 EP4698152 A1 EP 4698152A1
Authority
EP
European Patent Office
Prior art keywords
acid
pharmaceutical composition
cellulose
solution
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24733697.7A
Other languages
English (en)
French (fr)
Inventor
Denisa STRÁNSKÁ
Pavel BOSTIK
Gyan SAGAR
Sylva JANOVSKÁ
Radek Sleha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instar Technologies AS
Original Assignee
Instar Technologies AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instar Technologies AS filed Critical Instar Technologies AS
Publication of EP4698152A1 publication Critical patent/EP4698152A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
EP24733697.7A 2023-04-21 2024-04-20 Pharmazeutische zusammensetzung zur impfung gegen cytomegalovirusinfektionen Pending EP4698152A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2023162 2023-04-21
PCT/IB2024/053866 WO2024218752A1 (en) 2023-04-21 2024-04-20 Pharmaceutical composition for vaccination against cytomegalovirus infections

Publications (1)

Publication Number Publication Date
EP4698152A1 true EP4698152A1 (de) 2026-02-25

Family

ID=91582147

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24733697.7A Pending EP4698152A1 (de) 2023-04-21 2024-04-20 Pharmazeutische zusammensetzung zur impfung gegen cytomegalovirusinfektionen

Country Status (2)

Country Link
EP (1) EP4698152A1 (de)
WO (1) WO2024218752A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010571A1 (it) * 2001-03-19 2002-09-19 Grisotech S A Vaccini assorbibili per via trans-mucosale
CZ20032421A3 (cs) 2003-09-08 2004-11-10 Technická univerzita v Liberci Způsob výroby nanovláken z polymerního roztoku elektrostatickým zvlákňováním a zařízení k provádění způsobu
US9096845B2 (en) * 2007-08-29 2015-08-04 Technion Research & Development Foundation Limited Encapsulation of bacteria and viruses in electrospun fibers
US20110305768A1 (en) * 2008-07-01 2011-12-15 The Johns Hopkins University Quick-dissolving oral thin film for targeted delivery of therapeutic agents
KR20250006307A (ko) * 2017-09-13 2025-01-10 사노피 파스퇴르 인간 시토메갈로바이러스 면역원성 조성물
AU2019364823B2 (en) * 2018-10-25 2025-10-30 Km Biologics Co., Ltd. Modified CMV gB protein and CMV vaccine including same
EP4041190A1 (de) * 2019-10-08 2022-08-17 Afyx Therapeutics A/S Zusammensetzungen für die abgabe von proteinen

Also Published As

Publication number Publication date
WO2024218752A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
Chen et al. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination
EP0724431B1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
US20030017195A1 (en) Method for oral drug delivery
US20210085598A1 (en) Microneedle comprising silk fibroin applied to a dissolvable base
DE69836268T2 (de) Immunverstärkende Zusammensetzung in fester Verabreichungsform mit Kollagen oder Polydimethylsiloxan als Trägersubstanzen
Bailey et al. Self-encapsulating poly (lactic-co-glycolic acid)(PLGA) microspheres for intranasal vaccine delivery
US10245319B2 (en) Lymph node-targeting nanoparticles
AU2007288442A1 (en) Nanofiber structures on asperities for sequestering, carrying and transferring substances
CN102552919B (zh) 一种给药组合物及其制备和使用方法
CN111511434A (zh) 活性药物物质的口服递送
WO2018033744A1 (en) Carrier
CN1128953A (zh) 水凝胶微囊包封的疫苗
JP2019503352A (ja) 徐放性シクロスポリン添加微粒子
JP2022552832A (ja) タンパク質の送達のための組成物
CN111936160B (zh) 通过施用抗原特异性配制品治疗免疫性疾病
EP3137111A1 (de) Zusammensetzungen und verfahren zur intradermalen impfstoffverabreichung
US20170224612A1 (en) Mucoadhesive carriers of particles, method of preparation and uses thereof
EP4698152A1 (de) Pharmazeutische zusammensetzung zur impfung gegen cytomegalovirusinfektionen
Murillo et al. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity
KR102891374B1 (ko) 백신 전달을 위한 마이크로니들 패치 및 이의 제조 방법
Leroux et al. Development of an oral nanovaccine for dogs against Echinococcus granulosus
CN117281765B (zh) 一种诱发黏膜免疫应答的微针贴片疫苗及其制备方法与应用
KR101549137B1 (ko) 음이온성 단백질 약물 전달을 위한 키토산 코팅 나노섬유, 그 제조방법, 및 그 키토산 코팅 나노섬유를 포함하는 경점막 투여제
Beukema Intradermal administration of influenza accine ith trehalose and pullulan-based dissol ing microneedle arra s
WO2025021300A1 (en) A pharmaceutical formulation for the delivery of vaccines and other nucleic acid therapeutics using bilayer mucoadhesive film

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR